Header Logo

Connection

Yoshiko Usami to Humans

This is a "connection" page, showing publications Yoshiko Usami has written about Humans.
Connection Strength

0.157
  1. Usami Y, Wu Y, G?ttlinger HG. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef. Nature. 2015 Oct 08; 526(7572):218-23.
    View in: PubMed
    Score: 0.019
  2. Usami Y, Popov S, G?ttlinger HG. The Nef-like effect of murine leukemia virus glycosylated gag on HIV-1 infectivity is mediated by its cytoplasmic domain and depends on the AP-2 adaptor complex. J Virol. 2014 Mar; 88(6):3443-54.
    View in: PubMed
    Score: 0.017
  3. Usami Y, G?ttlinger H. HIV-1 Nef responsiveness is determined by Env variable regions involved in trimer association and correlates with neutralization sensitivity. Cell Rep. 2013 Nov 14; 5(3):802-12.
    View in: PubMed
    Score: 0.017
  4. Usami Y, Popov S, Weiss ER, Vriesema-Magnuson C, Calistri A, G?ttlinger HG. Regulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A. J Virol. 2012 Apr; 86(7):3746-56.
    View in: PubMed
    Score: 0.015
  5. Usami Y, Popov S, Popova E, Inoue M, Weissenhorn W, G G?ttlinger H. The ESCRT pathway and HIV-1 budding. Biochem Soc Trans. 2009 Feb; 37(Pt 1):181-4.
    View in: PubMed
    Score: 0.012
  6. Usami Y, Popov S, Popova E, G?ttlinger HG. Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J Virol. 2008 May; 82(10):4898-907.
    View in: PubMed
    Score: 0.011
  7. Usami Y, Popov S, G?ttlinger HG. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. J Virol. 2007 Jun; 81(12):6614-22.
    View in: PubMed
    Score: 0.011
  8. Olety B, Usami Y, Peters P, Wu Y, G?ttlinger H. The ectodomain sheddase ADAM10 restricts HIV-1 propagation and is counteracted by Nef. Sci Adv. 2025 Apr 18; 11(16):eadt1836.
    View in: PubMed
    Score: 0.009
  9. Usami Y, Oki T, Nakai M, Sagisaka M, Kaneda T. A simple HPLC method for simultaneous determination of lopinavir, ritonavir and efavirenz. Chem Pharm Bull (Tokyo). 2003 Jun; 51(6):715-8.
    View in: PubMed
    Score: 0.008
  10. Olety B, Usami Y, Wu Y, Peters P, G?ttlinger H. AP-2 Adaptor Complex-Dependent Enhancement of HIV-1 Replication by Nef in the Absence of the Nef/AP-2 Targets SERINC5 and CD4. mBio. 2023 02 28; 14(1):e0338222.
    View in: PubMed
    Score: 0.008
  11. Dai W, Usami Y, Wu Y, G?ttlinger H. A Long Cytoplasmic Loop Governs the Sensitivity of the Anti-viral Host Protein SERINC5 to HIV-1 Nef. Cell Rep. 2018 01 23; 22(4):869-875.
    View in: PubMed
    Score: 0.006
  12. Miyauchi K, Sugimoto-Ishige A, Harada Y, Adachi Y, Usami Y, Kaji T, Inoue K, Hasegawa H, Watanabe T, Hijikata A, Fukuyama S, Maemura T, Okada-Hatakeyama M, Ohara O, Kawaoka Y, Takahashi Y, Takemori T, Kubo M. Protective neutralizing influenza antibody response in the absence of T follicular helper cells. Nat Immunol. 2016 Dec; 17(12):1447-1458.
    View in: PubMed
    Score: 0.005
  13. Weissenhorn W, Miguet N, Aschman N, Renesto P, Usami Y, Gottlinger HG. Structural basis of tetherin function. Curr HIV Res. 2012 Jun; 10(4):298-306.
    View in: PubMed
    Score: 0.004
  14. Martinelli N, Hartlieb B, Usami Y, Sabin C, Dordor A, Miguet N, Avilov SV, Ribeiro EA, G?ttlinger H, Weissenhorn W. CC2D1A is a regulator of ESCRT-III CHMP4B. J Mol Biol. 2012 May 25; 419(1-2):75-88.
    View in: PubMed
    Score: 0.004
  15. Solomons J, Sabin C, Poudevigne E, Usami Y, Hulsik DL, Macheboeuf P, Hartlieb B, G?ttlinger H, Weissenhorn W. Structural basis for ESCRT-III CHMP3 recruitment of AMSH. Structure. 2011 Aug 10; 19(8):1149-59.
    View in: PubMed
    Score: 0.004
  16. Zamborlini A, Usami Y, Radoshitzky SR, Popova E, Palu G, G?ttlinger H. Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding. Proc Natl Acad Sci U S A. 2006 Dec 12; 103(50):19140-5.
    View in: PubMed
    Score: 0.003
  17. Muziol T, Pineda-Molina E, Ravelli RB, Zamborlini A, Usami Y, G?ttlinger H, Weissenhorn W. Structural basis for budding by the ESCRT-III factor CHMP3. Dev Cell. 2006 Jun; 10(6):821-30.
    View in: PubMed
    Score: 0.003
  18. Oki T, Usami Y, Nakai M, Sagisaka M, Ito H, Nagaoka K, Mamiya N, Yamanaka K, Utsumi M, Kaneda T. Pharmacokinetics of lopinavir after administration of Kaletra in healthy Japanese volunteers. Biol Pharm Bull. 2004 Feb; 27(2):261-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.